A new bill could empower pharmacists to offer cheaper biosimilars instead of costly biologic drugs, but patient advocates are raising concerns about potential out-of-pocket costs at the pharmacy.
Click to read more!
#WA #CitizenPortal #BiosimilarUtilization #PrescriptionCosts #PatientAccess
Click to read more!
#WA #CitizenPortal #BiosimilarUtilization #PrescriptionCosts #PatientAccess
Committee hears bill to let pharmacists substitute biosimilars; supporters tout savings, advocates warn of point-of-sale cost risk
The House Health Care and Wellness Committee heard Gross Second Substitute Senate Bill 5,594 to add biosimilars to state substitution rules and allow carriers to require a biosimilar trial before covering branded biologics starting 01/01/2027. Proponents said it lowers costs; patient advocates cautioned about out-of-pocket costs at the pharmacy counter.
citizenportal.ai
February 20, 2026 at 8:02 AM
A new bill could empower pharmacists to offer cheaper biosimilars instead of costly biologic drugs, but patient advocates are raising concerns about potential out-of-pocket costs at the pharmacy.
Click to read more!
#WA #CitizenPortal #BiosimilarUtilization #PrescriptionCosts #PatientAccess
Click to read more!
#WA #CitizenPortal #BiosimilarUtilization #PrescriptionCosts #PatientAccess